Search for: "HATCH v. WYETH"
Results 1 - 20
of 65
Sort by Relevance
|
Sort by Date
27 Aug 2017, 10:01 pm
FTC v. [read post]
27 Aug 2017, 10:01 pm
FTC v. [read post]
18 Jan 2016, 5:00 am
Our poston Yates v. [read post]
28 Aug 2014, 7:27 am
Wyeth Inc., No. [read post]
11 Jul 2014, 10:13 am
App. 2008), and the now reargued Wyeth, Inc. v. [read post]
12 Jun 2014, 10:46 am
Here, the court analogized to Wyeth v. [read post]
20 Mar 2014, 4:15 am
At the time of the IPR filings Apotex was involved in litigation while Ranbaxy was not although the patents had been asserted against others, see IPRs 2013-00012 (Apotex v Alcon), 00015 (Apotex v Alcon), and 00024 (Ranbaxy v Vertex). [read post]
14 Nov 2013, 7:41 am
Medtronic, Inc., 552 U.S. 312 (2008), Wyeth v. [read post]
31 Oct 2013, 5:00 am
The facts sound rather like Wyeth v. [read post]
12 Sep 2013, 7:37 am
So we’ve decided to take the plunge.We don’t have much quarrel with Dean Chemerinsky’s initial observation that the existing regime for preemption and prescription drug product liability litigation, fashioned by the trilogy of Wyeth v. [read post]
22 Aug 2013, 9:59 pm
This time the issue is not that the parties, Wyeth (branded) and Teva (generic) have entered into a reverse payment settlement agreement in their ANDA litigation under the Hatch-Waxman Act. [read post]
24 Jun 2013, 12:50 pm
In Bartlett v. [read post]
18 Jan 2013, 2:06 pm
Wyeth, 168 Cal. [read post]
27 Dec 2012, 3:47 pm
Wyeth LLC, 872 F. [read post]
2 Aug 2012, 10:17 am
This is in contrast to the Court’s March 4, 2009 decision in Wyeth v. [read post]
22 Jun 2012, 2:23 pm
Wyeth, Inc., 657 F.3d 420 (6th Cir. 2011) — is no more availing now. [read post]
6 Jun 2012, 5:35 am
But the plaintiff was allowed to argue, based on the general CBE-based non-preemption principles of Wyeth v. [read post]
23 May 2012, 2:38 pm
Bartlett v. [read post]
7 May 2012, 5:00 am
Two, since both Mensing and Wyeth v. [read post]
9 Jan 2012, 6:24 pm
Supreme Court’s March 2009 decision in Wyeth v. [read post]
